AACR-NCI-EORTC conference highlights main expansion in cancer drug pipeline The last decade has seen a significant expansion in the cancer drug pipeline and studies are continually underway to advance the arsenal of drugs and create more effective treatments and targeted therapies for patients. To highlight results of more recent research, the AACR-NCI-EORTC Molecular Targets and Tumor Therapeutics International Meeting will host a press briefing on ‘Drugs in the Pipeline.’ Sara A priligy 30 . Courtneidge, Ph.D., D.Sc., director and professor of the Tumor Microenvironment Plan, and director of academic affairs at the Burnham Institute for Medical Research, will moderate this press briefing. ‘Conferences like the AACR-NCI-EORTC Molecular Targets and Tumor Therapeutics International Conference play a very important function in advancing translational cancer research.
Generally images are viewed at pc workstations with standard display screens. University of Pittsburg College of Medicine experts wondered whether handheld gadgets like the iPhone would work equally well. Related StoriesMigraines may increase risk of stroke among smokersIRIDEX launches novel intra-ocular pressure monitoring deviceCalcitonin-gene related peptide antibody inhibition shows migraine avoidance promiseIn the study, Eyesight M.D.s from the University of Pittsburg Attention Center evaluated three aspects of diabetic retinopathy, a blinding disease that impacts many people with diabetes potentially, by reviewing both standard computer monitor and iPhone pictures for 55 patients .